|
Global Learning Disability Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Huntington's Disease Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Tuberculosis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Hypercholesterolemia Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Dermatology Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global AIDS Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Head and Neck Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global In Vitro Diagnostics Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
660 |
Global |
$2,995.00 |
|
|
Global Prenatal Screening Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Stroke Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Drug Addiction Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Peptic Ulcer Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Ebola Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Myocardial Infarction Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Central Nervous System Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
600 |
Global |
$3,495.00 |
|
|
Global Obstetrics Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
200 |
Global |
$2,995.00 |
|
|
Global Inflammation Partnering 2012 to 2018 |
Sep 1 2018 |
200 |
Global |
$1,995.00 |
|
|
Global Cancer Diagnostics Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
700 |
Global |
$2,995.00 |
|
|
Global Bone Fracture Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Epilepsy Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018 |
Mar 30 2018 |
104 |
Global |
$2,995.00 |
|
|
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies |
Feb 1 2018 |
106 |
Global |
$2,995.00 |
|
|
Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance |
Jan 1 2018 |
73 |
Global |
$6,995.00 |
|
|
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis |
Jan 1 2018 |
79 |
Global |
$2,995.00 |
|
|
PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
185 |
Global |
$10,995.00 |
|
|
PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
280 |
Global |
$10,995.00 |
|
|
Elan Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Gastrointestinal Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
700 |
Global |
$2,995.00 |
|
|
Global AIDS Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
